Lifeward LFWD
NASDAQ LFWD
$7.36 +0.15 (+2.12%)
At close: Aug 20, 2026 · 12:12 PM UTC

Lifeward (LFWD) Non-Current Deffered Revenue (2014 - 2026)

Lifeward (LFWD) posted Non-Current Deffered Revenue of $1.2 million for Q1 2026, down 2.03% sequentially from $1.2 million in Q4 2025, and up 2.98% YoY from $1.2 million in Q1 2025.

Lifeward (LFWD) Non-Current Deffered Revenue (2014 - 2026) Analysis & Trends

Lifeward has reported Non-Current Deffered Revenue for 13 years, with the latest figure at $1.2 million in Q1 2026.

  • Quarterly Non-Current Deffered Revenue rose 2.98% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 2.98% YoY) and the FY2025 annual result came in at $1.2 million, down 6.87% from the prior year.
  • Non-Current Deffered Revenue fell to $1.2 million in Q1 2026 per LFWD's latest filing, from $1.2 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $1.6 million in Q3 2023 and troughed at $808000.0 in Q3 2022.
  • A 5-year average of $1.1 million and a median of $1.2 million in 2026 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2023 and 2024: Non-Current Deffered Revenue jumped 103.59% in 2023, then declined 20.91% in 2024.
  • Over 5 years, Non-Current Deffered Revenue stood at $890000.0 in 2022, then surged by 69.21% to $1.5 million in 2023, then decreased by 12.08% to $1.3 million in 2024, then declined by 6.87% to $1.2 million in 2025, then dropped by 2.03% to $1.2 million in 2026.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $1.2 million, $1.2 million, and $1.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn -
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn -
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn -
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn -
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn -
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn -
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn 539.34 Mn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn -
10 Lifeward 20.39 Mn 10.94 Mn 2.71 Mn 1.24 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.21 Mn
Dec 31, 2025 1.23 Mn
Sep 30, 2025 1.21 Mn
Jun 30, 2025 1.18 Mn
Mar 31, 2025 1.17 Mn
Dec 31, 2024 1.32 Mn
Sep 30, 2024 1.30 Mn
Jun 30, 2024 1.31 Mn
Mar 31, 2024 1.36 Mn
Dec 31, 2023 1.51 Mn
Sep 30, 2023 1.65 Mn
Jun 30, 2023 841,000.00
Mar 31, 2023 895,000.00
Dec 31, 2022 890,000.00
Sep 30, 2022 808,000.00
Jun 30, 2022 810,000.00
Mar 31, 2022 825,000.00
Dec 31, 2021 866,000.00
Sep 30, 2021 763,000.00
Jun 30, 2021 727,000.00